Get startedLog in
    Picture of Kiniksa Pharmaceuticals International logo

    KNSA — Kiniksa Pharmaceuticals International News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Kiniksa Pharmaceuticals Q4 EPS USD 0.36

    Picture of Kiniksa Pharmaceuticals International logoKiniksa Pharmaceuticals International
    28/02/2024 12:30
    Feb 28 (Reuters) - Kiniksa Pharmaceuticals Q4 net income USD 25.237 million.
* Q4 pretax profit USD 2.45 million
* Q4 product revenue USD 71.22 million
* Q4 operating expenses USD 83.314 million

    Recent news on Kiniksa Pharmaceuticals International

    See all news